Beth A. Birnbaum
Known title: DirectorCIK: 0001754374
Associated companies
Transaction History
| ROOT | ▲ Buy | Grant | 2,864 | $0 | 6/3/2026 | View on chart |
| ROOT | ▼ Sell | Open Market | 289 | $41K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 95 | $14K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 381 | $53K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 99 | $13K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 592 | $83K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 158 | $22K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 128 | $18K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 341 | $46K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 129 | $17K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 51 | $7K | 6/5/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 589 | $82K | 6/5/2025 | View on chart |
| ROOT | ▲ Buy | Grant | 1,119 | $0 | 6/4/2025 | View on chart |
| ROOT | ▼ Sell | Open Market | 1,735 | $76K | 6/13/2024 | View on chart |
| ROOT | ▲ Buy | Grant | 2,305 | $0 | 6/5/2024 | View on chart |
| ROOT | ▲ Buy | Grant | 7,792 | $0 | 8/16/2023 | View on chart |
| ROOT | ▲ Buy | Grant | 115,207 | $0 | 6/7/2022 | View on chart |
| ROOT | ▲ Buy | Grant | 22,518 | $0 | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Wells Fargo cuts Root price target to $47
Wells Fargo lowered its price target for Root to $47 while maintaining an Equal-Weight rating. This adjustment occurs as the stock trades near its 52-week low, with the new target sitting below the current average analyst estimate of $57. The move reflects a more cautious outlook for the insurer amidst broader industry developments.
Wells Fargo cuts Root price target to $47. Wells Fargo lowered its price target for Root to $47 while maintaining an Equal-Weight rating. This adjustment occurs as the stock trades near its 52-week low, with the new target sitting below the current average analyst estimate of $57. The move reflects a more cautious outlook for the insurer amidst broader industry developments.